20th Paragraph IV Disputes 2024 | American Conference Institute | 25 April 2024 | Second Floor Nyc, 849 6th Ave, New York, NY 10001, USA

Join us as we take a retrospective look at the impactful court cases, pivotal legislation, and industry shifts that have defined the patent endgame and the pursuit of profits. As we cast our gaze forward and consider the future in an evolving legal and regulatory landscape, we also reflect on the journey thus far. Now is the time to strategize for the road ahead, ensuring that every pharmaceutical IP attorney is equipped for the changes to come.

Leaders from brand-name and generic drug companies alike acknowledge the unmatched value of our conference – the only event that caters to all sides of the industry with critical legal insights and strategic economic takeaways. We cover the most pressing matters – but also contextualize them within the entire patent lifecycle under Hatch-Waxman, from pre-suit considerations to case filings and final adjudication.

2024 Speakers

DISTINGUISHED CHAIRS:

Andrei Iancu
Partner, Sullivan & Cromwell LLP

Brian Malkin
Associate General Counsel, Teva Pharmaceuticals

Mira Mulvaney
Assistant General Patent Counsel IP Litigation, Eli Lilly & Company

2024 Sponsors

SUPPORTING SPONSOR:
• McDermott Will & Emery

ASSOCIATE SPONSORS:
• Abe & Partners
• BRG
• Kirkland & Ellis
• Latham&Watkins
• Venable LLP
• Young Conaway

LANYARD & DAY 1 LUNCHEON SPONSOR:
• Wit

COCKTAIL RECEPTION SPONSOR:
• Loeb & Loeb LLP